Markets:

Overview

News

Currencies

International

Treasuries

Can-Fite Biopharma Ltd Sponsored ADR (Israel) (NY:CANF)

0.3390 -0.0030 (-0.88%)

Official Closing Price Updated: 4:10 PM EST, Dec 4, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Can-Fite Biopharma Ltd Sponsored ADR (Israel)

< Previous 1 2 3 4 5 6 7 Next >

In today's session, these stocks are experiencing unusual volume. ↗

November 19, 2025

Let's explore the current happenings on the US markets on Wednesday. Below, you'll find the stocks exhibiting unusual volume in today's session.

Via Chartmill

Tuesday's after hours session: top gainers and losers ↗

November 18, 2025

As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

Which stocks are most active on Tuesday? ↗

November 18, 2025

Discover the most active stocks in Tuesday's session. Stay informed about the stocks that are generating the most trading volume!

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

November 18, 2025

Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

Dow Falls Over 300 Points; Home Depot Posts Downbeat Earnings ↗

November 18, 2025

Via Benzinga

Topics Stocks

These stocks that are showing activity before the opening bell on Tuesday. ↗

November 18, 2025

As the US market prepares to open on Tuesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 18, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's pre-market session. ↗

September 30, 2025

The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 30, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 22, 2025

Via Benzinga

Top movers in Monday's session ↗

July 28, 2025

Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 28, 2025

Via Benzinga

bioAffinity Technologies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

March 28, 2025

Via ACCESS Newswire

Unusual volume stocks in Thursday's session ↗

March 20, 2025

Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 19, 2025

Via Benzinga

60 Degrees Pharmaceuticals and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

November 22, 2024

Via ACCESSWIRE

OS Therapies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

August 09, 2024

Via ACCESSWIRE

Positive Results from Osteoarthritis Clinical Study in Dogs Reported by Can-Fite’s Partner Vetbiolix

June 28, 2024

From Can-Fite BioPharma Ltd.

Via Business Wire

Can-Fite: Breakthrough Findings Demonstrate Namodenoson Anti-cancer and Protective Effect Mechanism in the Liver

June 24, 2024

From Can-Fite BioPharma Ltd.

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

June 14, 2024

Via Benzinga

Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 14, 2024

Via Benzinga

Can-Fite Received IRB Approval for the Treatment of Pancreatic Cancer with Namodenoson in a Phase IIa Study

June 10, 2024

From Can-Fite BioPharma Ltd.

Via Business Wire

Can-Fite Updates on its Advanced Liver Cancer Pivotal Phase 3 Study

June 05, 2024

From Can-Fite BioPharma Ltd.

Via Business Wire

Independent Scientists Published a Review Article Demonstrating That Can-Fite Drugs Have Therapeutic Effects on Heart Diseases

May 29, 2024

From Can-Fite BioPharma Ltd.

Via Business Wire

Can-Fite to Participate in Partnering Meetings at Bio International Convention 2024

May 27, 2024

From Can-Fite BioPharma Ltd.

Via Business Wire

Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on June 6

May 23, 2024

From Can-Fite BioPharma Ltd.

Via Business Wire

Can-Fite: 75 Oncologists and Coordinators from Europe US and Israel Participated in a Conference Aimed at Accelerating Patient Enrolment for the Pivotal Phase 3 Advanced Liver Cancer Study

May 13, 2024

From Can-Fite BioPharma Ltd.

Via Business Wire

Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

May 10, 2024

Via ACCESSWIRE

Can-Fite: FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study

May 09, 2024

From Can-Fite BioPharma Ltd.

Via Business Wire

Can-Fite Received Notice of Allowance from the European Patent Office for the Treatment of Erectile Dysfunction with CF602

May 06, 2024

From Can-Fite BioPharma Ltd.

Via Business Wire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.